Over the last 10 years, volunteers in the Parkinson's Progression Markers Initiative (PPMI) have helped expand our understandi
![Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort](https://www.frontiersin.org/files/Articles/762759/fnagi-13-762759-HTML/image_m/fnagi-13-762759-g001.jpg)
Frontiers | Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort
![Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts | npj Parkinson's Disease Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-022-00439-z/MediaObjects/41531_2022_439_Fig1_HTML.png)
Identification and prediction of Parkinson's disease subtypes and progression using machine learning in two cohorts | npj Parkinson's Disease
Did you know that if you printed PPMI data, it would reach to the moon and back? Our Parkinson's Progression Markers Initiative (PPMI) shares its robust... | By The Michael J. Fox
![Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2017/05/0037-001133_001.jpg)
Cognitive data in the Parkinson's Progression Markers Initiative: Comparison of normative data approaches - MDS Abstracts
The Michael J. Fox Foundation for Parkinson's Research - Everyday people just like you, with and without Parkinson's, have taken the first step to join our Parkinson's Progression Markers Initiative study to
![New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation](https://nyscf.org/wp-content/uploads/2013/10/7fff74282c8cdbb70e66b6fc74f9ad94_XL.jpg)
New York Stem Cell Foundation Announces Partnership with Parkinson's Progression Markers Initiative - New York Stem Cell Foundation
![Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/0dda957a-5bbe-4ce4-9f7e-d6d277883585/gr1_lrg.jpg)
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study - The Lancet Neurology
![Cleveland Clinic Lou Ruvo Center for Brain Health Joins Michael J. Fox Foundation's Expansion of Parkinson's Progression Markers Initiative (PPMI) – Cleveland Clinic Newsroom Cleveland Clinic Lou Ruvo Center for Brain Health Joins Michael J. Fox Foundation's Expansion of Parkinson's Progression Markers Initiative (PPMI) – Cleveland Clinic Newsroom](https://newsroom.clevelandclinic.org/wp-content/uploads/sites/4/2023/04/Zoltan-Mari-MD-lab-coat-PS5_3405-2-2.jpg)